Arcadia Biosciences, Inc.
RKDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,317 | -$13,986 | -$15,612 | -$16,134 |
| Dep. & Amort. | $765 | $287 | $479 | $1,045 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $717 | $1,106 | $1,541 |
| Change in WC | -$1,446 | -$2,744 | $1,050 | -$2,920 |
| Other Non-Cash | -$4,629 | $432 | -$1,000 | -$9,400 |
| Operating Cash Flow | -$9,627 | -$15,294 | -$13,977 | -$25,868 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,016 | -$5 | -$72 | -$1,007 |
| Net Acquisitions | $334 | $569 | $569 | -$4,250 |
| Inv. Purchases | $0 | -$7,525 | $0 | $0 |
| Inv. Sales/Matur. | $5,024 | $2,502 | $0 | $21,846 |
| Other Inv. Act. | $4,000 | $115 | $920 | $19 |
| Investing Cash Flow | $7,342 | -$4,344 | $1,417 | $16,608 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$2,146 |
| Stock Issued | $9 | $5,997 | $5,000 | $25,147 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$485 | -$481 | -$1,101 |
| Financing Cash Flow | $9 | $5,512 | $4,519 | $21,900 |
| Forex Effect | $0 | $0 | $0 | $2 |
| Net Chg. in Cash | -$2,276 | -$14,126 | -$8,041 | $12,642 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,518 | $20,644 | $28,685 | $16,043 |
| End Cash | $4,242 | $6,518 | $20,644 | $28,685 |
| Free Cash Flow | -$9,643 | -$15,299 | -$14,049 | -$26,875 |